RepliCel Launches Preparations for Second Skin Rejuvenation and Tendon Regeneration Clinical Studies May 19, 2021
What healthcare stocks are heating up? – June 10, GCFF Healthcare Virtual Event May 17, 2021 Life Science, Technology
RepliCel Announces Appointment of Leading Dermatologist in Japan as Clinical Advisor May 17, 2021 Life Science, Technology
RepliCel Launches the Next Stage of a Research Project with the University of British Columbia to Build World-Class Hair Follicle Cell Data Map May 11, 2021 Life Science, Technology
RepliCel Announces Appointment of Leading Sports Medicine Expert as Orthopedics Clinical Advisor (Japan) May 3, 2021 Life Science, Technology
Hemostemix Provides a Clinical Trial Update and Announces the Release and Filing of 2020 Year-end Audited Financial Statements and Management Discussion and Analysis Apr 30, 2021 Life Science, Technology
Rethinking the approach to diagnose cancer | VolitionRx Limited Apr 30, 2021 Life Science, Technology
RepliCel Closes Second Tranche of Strategic Investment Commitment Apr 29, 2021 Life Science, Technology
Hemostemix Reprices and Amends the Terms of Its Unit Offering and Debenture Offering Apr 26, 2021 Life Science, Technology
Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up and HMTXF Up-list Apr 23, 2021 Life Science, Technology
RepliCel Life Sciences Announces Intention to Pay Dividend on Preferred Shares Mar 31, 2021 Life Science, Technology
RepliCel Presents Its Technology Development and Commercialization Plans for Japan at Kanagawa Regenerative Medicine Industry Conference Feb 18, 2021 Life Science, Technology
Healthcare Roundup – Sesen price target raised on prospects for bladder cancer therapy; Sundial makes $22M investment in cannabis edibles company Indiva Feb 16, 2021 Life Science
Healthcare Roundup – G1 Therapeutics jumps 16.9% as trilaciclib wins FDA approval; Bionano Genomics shares hit all-time high, spiking nearly 23% Feb 12, 2021 Life Science
